Glassman Wealth Services Legend Biotech Corp Transaction History

Glassman Wealth Services

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$63.16 - $76.5 $2,905 - $3,519	-46 Reduced 16.43%	234 $15,000
Q2 2023 Aug 08, 2023	SELL	$46.28 - $75.01 $4,489 - $7,275	-97 Reduced 25.73%	280 $19,000
Q1 2023 May 04, 2023	SELL	$43.42 - $57.37 $1,997 - $2,639	-46 Reduced 10.87%	377 $18,000
Q4 2022 Feb 06, 2023	BUY	$38.8 - $55.46 $2,987 - $4,270	77 Added 22.25%	423 $21,000
Q2 2022 Aug 04, 2022	BUY	$33.54 - $55.0 $3,521 - $5,775	105 Added 43.57%	346 $19,000
Q1 2022 Apr 14, 2022	SELL	$31.02 - $48.18 $5,552 - $8,624	-179 Reduced 42.62%	241 $9,000
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $17,278 - $23,931	420 New	420 $20,000

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.12B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.